Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: Results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

Nicola Di Renzo, Antonella Montanini, Donato Mannina, Alessandra Dondi, Stefania Muci, Salvatrice Mancuso, M. Rosaria De Paolis, Caterina Plati, Caterina Stelitano, Catia Patti, Attilio Olivieri, Eliana Liardo, Gabriele Buda, Renato Cantaffa, Massimo Federico

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: Results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)'. Together they form a unique fingerprint.

Medicine & Life Sciences